Key Takeaways
Vaginal atrophy is treatable with topical estrogen, even when some changes don't fully reverse
Dr. Brown explained that vaginal estrogen cream helps restore elasticity, moisture, and function to tissue affected by atrophy. She noted that significant changes in size, such as to the clitoris or labia, may not fully reverse, but treatment still meaningfully improves comfort and sensation.
Heart palpitations are common in perimenopause, but heart symptoms still deserve serious attention
Dr. Brown explained that fluctuating estrogen levels affect the heart's electrical conduction system, which can cause palpitations during the menopause transition. She emphasized that any concerning cardiac symptoms should still be evaluated in person by a doctor, noting that heart disease remains the leading cause of death for women overall.
Vaginal estrogen can meaningfully reduce recurrent UTIs
Dr. Brown discussed how declining estrogen thins the tissue around the urethra, making it easier for bacteria to reach the bladder. She said vaginal estrogen cream helps restore that tissue and can significantly reduce recurrent UTIs, especially for older postmenopausal women.
DHEA's benefits often become more limited later in the menopause transition
Dr. Brown clarified that DHEA can help with symptoms earlier in perimenopause, but as the ovaries produce less estrogen over time, DHEA alone often isn't enough. Many women end up adding hormone therapy as they get closer to their final period.
The safest window to start HRT is within 10 years of your last period and before age 60
Dr. Brown explained that this window matters most for postmenopausal women who haven't yet started treatment, since starting well outside it changes the balance of risks and benefits. She encouraged women within that window to consider treatment if they're experiencing bothersome symptoms.
